Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia

Published:2022-06-22 Issue:7 Volume:22 Page:813-820
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Pirillo Angela¹²,Catapano Alberico L.²³

Affiliation:

1. Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello Balsamo, Milan, Italy

2. Center for the Study of Dyslipidaemias, IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy

3. Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2090242

Reference52 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

2. Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis

3. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

5. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials;American Journal of Cardiovascular Drugs;2024-05-07

2. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023;Atherosclerosis Plus;2024-03

3. Nouveautés 2024 des anti-PCSK9;Archives des Maladies du Coeur et des Vaisseaux - Pratique;2024-03

4. Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa;Journal of Clinical Lipidology;2023-12

5. Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment;Reviews in Cardiovascular Medicine;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3